Subscribe
14 January 2014Patents

US Supreme Court agrees to hear Nautilus heart monitor case

On January 10, the US Supreme Court agreed to decide on so-called ambiguous patent claims in Nautilus v Biosig Instruments.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
Dow Chemical’s $30m award falls through Nautilus trapdoor
1 September 2015   A US appeals court has reversed a decision to award $30 million in supplemental damages to The Dow Chemical Company after finding that its patents were invalid under a standard established by the US Supreme Court’s Nautilus v Biosig ruling.


Editor's picks

Artificial Intelligence
UK govt aims for balancing act in ambitious AI plan
14 January 2025

Editor's picks

Artificial Intelligence
UK govt aims for balancing act in ambitious AI plan
14 January 2025
Trademarks
Should a musician’s headshot qualify for TM protection? ‘Yes’ says INTA
10 January 2025
Careers
Stobbs IP loses another senior partner to Addleshaw Goddard
9 January 2025
Patents
Dyson and SharkNinja settle patent dispute over vacuum technology
3 January 2025
Careers
CIPA’s new president to offer ‘stronger voice for in-house attorneys’
3 January 2025
Trademarks
Leading US trademark firms and lawyers recognised in new national rankings
23 December 2024

More articles

Hytera admits it stole Motorola’s trade secrets in case tied to DoJ charge
Will Walmart’s Birkin gambit be worth it in the end?
On our radar… Nvidia’s trade secret spat, Huawei settlement, and AI copyright cases
K&L Gates adds litigator in Melbourne
BakerHostetler adds experienced partner in Washington, DC
Nike sprints ahead in shoe patent race
How cautionary notices protect IP across Africa
‘Bleeding’ plant burger company dines out on EU patent win